Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study
NCT05046262 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2021-09-16
Summary
25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation
Conditions
Interventions
- DRUG
-
Calcium chloride
Calcium electroporation
Sponsors & Collaborators
-
Mirai Medical, Ireland
collaborator UNKNOWN -
Bispebjerg Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-08
- Primary Completion
- 2022-02-22
- Completion
- 2022-02-22
Countries
- Denmark
Study Locations
More Related Trials
-
Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00139269 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Improving Tumor Oxygenation in Cervical Cancer
NCT00257829 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
NCT02446652 ·Status: WITHDRAWN ·Phase: PHASE3
-
Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer
NCT05764044 ·Status: RECRUITING ·Phase: PHASE3
-
Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
NCT00176267 ·Status: COMPLETED ·Phase: PHASE2
-
Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer
NCT00629226 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
NCT01835626 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
NCT06236464 ·Status: RECRUITING
-
Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
NCT00198263 ·Status: COMPLETED ·Phase: PHASE4
-
Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid
NCT02608736 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer
NCT02794675 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
NCT06103669 ·Status: RECRUITING ·Phase: NA
-
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
NCT00140556 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
NCT00001442 ·Status: COMPLETED ·Phase: PHASE1
-
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
NCT00016926 ·Status: COMPLETED ·Phase: PHASE2
-
Proton Therapy for Locally Advanced Cervical Cancer
NCT06462378 ·Status: RECRUITING ·Phase: PHASE2
-
Ceramide NanoLiposome in Patients With Advanced Solid Tumors
NCT02834611 ·Status: COMPLETED ·Phase: PHASE1
-
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery
NCT01026792 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00139230 ·Status: COMPLETED ·Phase: PHASE2
-
Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).
NCT06448026 ·Status: RECRUITING ·Phase: PHASE2
-
Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix
NCT00178269 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
NCT05268614 ·Status: RECRUITING ·Phase: PHASE2
-
SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer
NCT00026260 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)
NCT00268671 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cervical Cancer
NCT00842660 ·Status: UNKNOWN ·Phase: PHASE3